merck. these days merck stock has become your classic low-moving big pharma dinosaur -- >> boo!the company doesn't get nearly enough credit for its incredibly deep pipeline or the terrific diabetes franchise and the great vaccine business and the anti-psychotic drug that causes much less weight gain than the competition and that's the great reason for people that have to take the drugs that go off because of the weight gain. >> the under the corroded hood of the company as it is now. simple. it needs to fl low the same game plan when they have cramer fife. merck has been on its own animal health business and it produced a 10% bump at the company's combined enterprise value and it split off the consumer division business and it gets almost no credit because it's in the pharma colossus which is merck. to either boost the dividend and it's got a good one, but how about the better one or increases buyback? altogether, this rally could cause a 20% rally with just the stroke of a pen. that's what would happen tomorrow. applied materials and amat, and the semiconductor equipment and it

these days merck stock has become your classic slow-moving, big pharma dinosaur. the company doesn't get nearly enough credit for its incredibly deep pipeline or it's terrific diabetes franchise and it's great vaccine business, not to mention its groundbreaking anti psychotic drug that causes much less weight gain than the competition. that's a big reason people have to take these drugs go off the medicines, because of the weight gain. how can work to get credit for all the things it's got going under the corroded to of the company it is now? it needs to follow the same game plan that pfizer used when they spawn off their animal business. merck can spin off its own animal health business and produce a 10% boggan the company's value and it can spin off its consumer division that generates nearly $2 billion in sales and gets the credit because it is buried within the colossus that his work. merck can use the capital to either boost the dividend, or to increase its buyback. altogether i think this rally could cause a 20% rally with just the stroke of a pen. that's wh

it's called suvorexant, merck's sleep drug currently seeking approval from the f.d.a.hich is inspired by research on narcoleptic dogs, which is is important work because nothing hurts your self-esteem like a dog falling asleep in the middle of humping your leg. (laughter) but, folks, suvorexant is effective without ambien's troubling side effects because it has exciting new side effects. one patient had a feeling as if shocked, then felt paralyzed and heard vivid sounds of people coming up the stairs with a sense of violent intent and another had a feeling of shadows falling over his body hunted by enemies hearing extremely loud screams. (laughter) now, of course, the easiest thing to do would be just label the bottle "warning, may cause sudden on set kafka." (cheers and applause) but instead, the f.d.a. told merck to drop the suggested dosage dramatically from 80 milligrams to 10 milligrams. unfortunately, at that level patients recorded it had no advantage over a placebo. well, the folks at prescott believe the government should not be putting a bureaucrat between yo

. >> merck is recalling some hpv vaccines because broken glass may be in the vials during the process the lot sent out between august ask october. cdc say patients may have swelling at the injection site. merck is contacting clinics so they can be concerned. >> a lot of concern about the situation at target. linda e mailed i usually use a debit card but didn't. should i be worried? >> no. look. this has been overblown and killing me here. look. this is the same kind of breech we have hundreds of per year the deal is that it's 40 million, a store we trust but for consumers issue is did it affect you? if you didn't use your card during that time, you're probably fine. those who use their cards are probably fine. just keep track of your bills every month. if you're keeping track you're going to be okay. >> stephanie e mailed i went to a college but that is no longer in business. now, i need proof for a job that i attended the school. >> this problem all the time. people go to post secondary education stint yugss then, it closes down. state says they have to keep them forever. but not whe

is a german company you've got by air is a german company you know merck is a swiss company the i mean you know i what. all final act so smith kline has has their major employers now in london they all have research arm of the united states they all file patents in the united states they all take advantage of our government to get on with their research you know our we pay and we're going to help out in system which i think is very important to developing these techniques what does any of that have to do with our not our having or not having a national health care system i mean isn't this a reminder isn't this this flu a reminder that we really need to be sure that everybody the united states one way or another has health insurance having more has access to health care you know well i personally think that the folks that need health care should be able to have health care but i also think that sort of the way that diseases spread is such that not everybody always needs to be inoculated not everyone needs to be quarantined and not everyone necessarily needs to be covered even if there a

was this in the merck manual? >> it was there until 1970. >> why did they take it out? was for space reasons. that's what they told another doctor i worked with who asked them. they took it out because of space reasons. >> this is something that has been a health tool for a very longtime. it gives you great results. it helps destress the liver and clean out the gall bladder and does amazing things for the body. you guys are big proponents of it. i am too. i must say i can't get up in the morning without one. thank you for coming on to talk about this. i think you will make a lot of thinner waistlines and smaller butts when the livers are working better. >>> up next, get your books out. i explain the difference of being ph balanced in today's ask carol. stick around. >>> welcome back. it is time to ask the question of the week in a segment apartmently named ask carol. baseball in the news tweeted, if your blood ph has a level of 6.5 why do you say people are acid? that's a good question. most people's blood ph is below the optimum 7.365. another way to say it is most peo

and i'm gonna vote with the drug cartels and buy merck and pfizer. alan: i don't think there's any phone stocks that i like. at&t is up 1% with the dow up 20% this year. it's ridiculous. it looks like dead money. and if you think about the names in that space, you've got sprint, blackberry. you've got a lot of dogs. i think you'd be better off to put your money elsewhere than i phones. i would be with the cartels. they're making money selling those stolen phones because there is technology that you can get to lock your phone now but phone companies don't do that because they want to sell insurance. angie: topic number 3: those rose colored glassesrose bowl tickets are going for all time highs. all the way up to 50 thousand dollars would you believe. is this a sign of greater wealth in the economy and is it a buy signal? alan: well, my friend scott here is a footballer. so he's an expert. but i think it's a healthy sign that people are paying a lot more for tickets now . people have more discretionary money. things are not great but they are getting b

merck is recalling guard sil. -- guard sil. only 10 vials may be affected but they are recalling the whole lot. that's 743 vials. the glass shards are small enough to fit through the needle. >>> the fda wants the food makers to make a plan to ward off terror attacks. the food facility would need to create a written good defense plan. the fda said such an attack is unlikely. >>> we have the long awaited results of an investigation into secret service misconduct. a report on new details involving alcohol and prostitution and bad behalf yore is putting the president's safety at risk. >> this report calls it isolated but the secret service needs to do a better job policing its agent. >> alcohol, prostitution and the u.s. secret service. congress ordered this investigation to find out if last year's prostitution scandal in columbia is regular routine with the law enforcement agency. >> really serious problem is this management and creates a culture agents say we can do what we want. when it comes to prostitution and alcohol, individ

. >> gsk is moving ahead, and it's likely that pfizer, merck and johnson & johnson will probably follow suit. not yet, we'll have to wait and see. >> so we told you earlier president obama spent a good portion of the day talking to leaders of the country's top technology firms about a talk as at the top of the hour. ali, good to see you. what is at stake here. theorists have talked about. and many feel like they should get the nsa should get their nose out of our business but iry here and we have to look at that carefully. >> so you're also looking at the big players behind the country's real chinese who are restricted of real estate purchase in their own country are coming right here. >> here on the program edward snowden bargains with brazil for possible asylum. the price? information about the united states spy programs. >>> and no matter who wins the mega millions jackpot, government will make a profit. where does that money go? that's next. night with the combatants in their training base. >> welcome back to al jazeera america. the united states is getting some of its personnel out

merck estimates only 10 might contain the tiny pieces of glass. -- stopping dead in her tracks.ere in the class this of replacing a highway with an underground tunnel. something underground stop the machine. geologists believe it could be a giant boulder from the last ice age. >> you find old shoes, newspapers, there is a boat buried in downtown seattle. you name it, it could be down there. >> those in charge of the project want to make sure they know what they are doing with before they go any further because they do not want to damage big eartha, the name of this five-story tall machine. >> and u.s. senator in the best spirit.-- festivus the grievances he is airing on twitter. ven on your side helps a her christmas wish. taking care of her son who has special needs. >> marines arrived at the station to pick up some toys provided by some of you viewers. there were there to help load up the toys without -- that are being sent out in southeast washington. enjoy. thanks to natasha they can get their a batteries for those stories. >> we are wondering how cold it will get for christ

higher by door to voice a -- deutsche divorce a -- borse and merck. we will see stocks and indices go off the board today. all agility will be the name of the game. the dollar index rises. fx volatility is dropping. pimco does not expect the dollar to rise much. the euro dollar drops by a quarter of one percent. it has had a good run. a couple of stocks and headlines. 25%.oil down . they have a big venture with london and there is a delay in production. they have just dropped back. bae down 4.2% as their deal falls apart with the uae in terms of the typhoon fighter jets. those are your markets. let's put them in context for you. our next guest, a little bit more on why he thinks that. andy lynch is a fund manager over at schroders. ray to have you with us. you are the christmas grinch. >> i am afraid so. i am here to deliver lots of bad news to lots of people who have been really happy. >> this paper program, there has been this initial good reaction. why is that? it is a bit paradoxical to what we have seen before. is it about the guidance we have gi

china like glaxo and merck will face more scrutiny from the u.s. the move comes after u.s.esident joe biden secured a commitment from the chinese government to allow more inspectors in the country. tablets are the bright spot in the global computing hardware front. that is unlikely to change in 2014. for more on hardware trends, i -- part of a team providing research on major sectors. great to have you on the program. we know that tablets are the way youngsters consume news and everything. 2014, it is going to bridge that gap between pcs and tablets. >> absolutely. the hardware industry has a mathematics problem. tablets are offsetting the mission in perspective some of that weakness. is other part of the trend also tablets as a consumption device. somee high end, there is replacement going on. the ipad, the high-end galaxy, you can do work on them. you can use that instead of buying a pc. end, or a significant amount of growth is occurring, particularly driven by china, a lot of people are using that as a media consumption device. separate from all of this, the pc lifecycl

here they are, intel, at&t, verizon, merck, none of their dividends returned more than the s&p. >> 2014that was a problem. and when you pick these high dividend yields, at the beginning of this year you had hewlett-packard which no one wanted, and it was in the strategy. it was the single reason that the dogs did not perform this year. liz: with id over what is the strategy you believe will work in 2014? >> we believe that bonds have not done well. there has been tax settlement news. the yield on some of these things, especially some of them yunis. prices are depressed. you can get a big january bounce in these things basically a mutual fund that trades like a stock. specifically closing bond funds. these things can trade at discounts to the value of the investment in the portfolio which is important because you can get a yield. if you have four to 5% yield in the municipal universe you can get six to 7% because they trade at a discount. a little leverage, but the prices are beaten down. liz: are their names? >> we made a list that we published. we published this a couple of days ago. m

biotech and the major biotech companies are providing the kind of growth that we used to expect from merckpfizer and glaxo smithklein and eli lilly in their heyday. i'm always willing to recommend stock names. i don't mind that, but you want to have a safer way to play this thing, you need to look at the four major biotech companies that become the logical errors to the old line household name, pharmaceutical stocks and the ones leading the revolution, hence why i call them the four horsemen of the big pharma apocalypse. and they are celgene, gilead, biogen and regeneron. all four of these stocks have had axe mazing runs this year. i'm well aware of that and i've been recommending them aggressively for a long time on the show. i think they're fantastic. celgene is basically a three-legged school of innovate of drugs. first one is made of the multiple myeloma franchise, which is a derivative of a poison. a poisonous drug. this drug has a lot of room to grow, particularly in europe. the second leg is apraksame. this is a potential blockbuster oncology drug approved for breast cancer and nons

. >> explain to me how you could have 100 million customers as varied as merck, ford, fedex, dell, procter are there commonalities of all of those that you do? >> sure. and this is one of the big macro trends that are going on, is that more and more companies out there are looking to learn about their own customers, and in order to do so, one of the best tools out there is to put together a loyalty program. by having a loyalty program, i'm able to then understand what you're buying, when you're buying, how you're buying, what motivates you to buy, and our job is to then figure out what can excite you to come back one extra time this quarter, two extra times this year. and if i do my job right, the roi on those types of investments are huge. >> whose ideas -- are you implementing or are you also coaching these clients? >> it's a combination of both. so you're talking about these massive, massive programs, everything from the city bank thank you network, hilton honors rewards, to a number of private label programs like victoria's secret and ann taylor like you mentioned. it's a combination o

leak the merck's announcement they said maybe we're not doing the right thing with the pipeline, let's create research centers. guess what? that's what big cap biotech is, and it's cheaper than big cap pharma on a p/e and growth basis. a couple of stocks i'm not going to hold on to, i don't owe them, yahoo! the val situation reflect -- valuation, it's put up or shut up by marissa mayers. she's limited in terms of the competition with dole and others. getting rid of the high flying internet stocks. not talking about a priceline which is reasonably valued, i'm talking of the twitters, facebooks. those stocks have to grow into their valuation this year and i'm not sure they're going to. >> dr. j., biotech, bone of the top of performers. a source of beta. i'm wondering where you stand on that. are there particular names. >> i like biotech, but it wasn't one of the areas of focus for me. pete is actually more positive on these guys than i am. i would not exit, i'd be in steven's camp. i would not exit biotechs, i still like them. ones to hold, i'd say likes of southern company, a utility, l

among his new clients were phrma, pfizer, lilly and merck. >> from a majority side of the finance committee linda fishman. >> fishman left to become a lobbyist with the drug manufacturer amgen. >> not the least of all but the energy and commerce committee staff who toiled so hard for us, chief of staff pat morrissey. >> morrissey took a job lobbying for drug companies novartis and hoffman-laroche. >> and jeremy allen. >> he went to johnson and johnson. >> kathleen weldon and jim barnett. >> she went to lobby for biogen, a biotech company. he left to lobby for hoffman-laroche. >> they did a marvelous job for this house and we owe them a debt. thank you all. >> we owe them all right. wow. yeah, i mean, this happens -- it happens with every bill. i mean, i think -- what was striking about that is congressman tauzin actually sort of -- if we sent a resume out on all of their behalf, by sort of doing a roll call in his remarks. but look, i mean, that -- the steve kroft piece was stunning in that i think he caught tauzin just, oddly flat-footed. i mean, i think we've seen in reading his face, he

you are the supply chain for merck, for example. >> we are excited about health care. 13, 14 years ween involved in health care. you have ramped up investments in recent times. the reality is they need to spend efforts and time on research and development and turn the supply chain over to you ups. we have wonderful technology. that goesetwork absolutely everywhere and experts of compliance. parts of thetical industry. it is a fast-growing industry with democrat vix what they are. >> in terms of health care, a bigger and bigger parts of the business. a lot of work you guys are doing. >> we do lots of things in health care. areave pharmacies that dispensing insulin pumps to get to diabetic -- diabetics the next day. it is a big area. home health care will be a big area in the future. much.nk you so >> scott davis. thank you. chairman and ceo of ups. >> coming up, we are talking about the major ruling that could yank 30% of goldman sachs revenue right off the books. vokerocal role -- lker rule next. ♪ >> the day wall street has been dreading has finally come. three years in the making bu

interesting to watch some of the other names, j&j, merck, we reached out to no comment there. we'll watch to see what they do on the front. >> the change in the business model and the way medicines were prescribed and sold. >> a lot of attention on this one. >> thanks very much. >> all right. let's move on now. seema, this could be a pretty bitter pill for lots of people to swallow. those especially who take vitamins. what is going on here and why now? >> here's the deal, medical experts revealed data on if we should take vitamins and here is their bottom line. >> i generally don't recommend vitamins. i recommend healthy dietary patterns and regular exercise because it's unnecessary. >> dr. miller and other researchers co-wrote a bold editorial that highlights the lack of benefits in taking vitamins and mineral supplements an how they may be even harmful. what's the solution? follow what your mother probably told you, which is to have a well balanced nutritious diet. not clear whether people will take dr. miller's advice because the vitamin and supplement industry has been a f

merck has not decided that. novartis has not decided that. have zoetis separate from pfizer? >> well, first they unlock significant value. >> unlock value. okay. >> now we have the opportunity to create the value to the shareholders of zoetis. >> but what does it mean? what are you able to get now as a separate company that you couldn't get when you were within pfizer? >> well, i would say the single focus on animal health. at pfizer they have different units, different opportunities for investment. now all the people that are working for zoetis are focused on creating a value and translate this value to the shareholders. >> i think this is a great story. no third party payer alone in a world where that's all i think about now from big pharma. this is a terrific story. i want to think juan ramon alaix, the ceo of zoetis. you got to look at this stock. i spent the weekend looking at this thing, and i can't believe i wasn't talking about it all along. it is a great story. "mad money" will be right back. >>> you bet today got ugly. we had a 3m d

now, contraction in merck, 6.9% in the third quarter but a 3.2% drop in earnings groetd. again, thanks to the buyback. now, over to home depot. home depot has consistently increased the amount it's bought back from 2009 to 2012. the latest quarter of home depot's net quarter drew but it crew 28%. shares are up 30% year to date. these buybacks may be good for shareholders in the short one but some analysts argue that companies who focus on buybacks to raise the stock price may be out of good ideas on how to invest their money to grow their businesses. andrew? >> thank you, seema. let's get over to sheila. try and find out which stocks are ripe for insider selling. >> we've been talking a lot about facebook and how mark zuckerberg has been cashing in on his shares. he is not alone. in fact, plenty of companies have been seeing insider selling. we screened the names of the companies who have had the top selling over the past 30 days. now, topping out the list is a apparel manufacturer pvh. $70 million worth sold by insiders. the bulk of that by ceo. he said it was related to

and you look at other things which have he mercked in terms of enduring strength in the klaas couple of years including our energy future. which si a big story coming out of 2013, united states today it is predicted will be the largest producer of oil by 2020 in the world. we're currently the largest producer of natural gasment you see reductions in the amount of, and the cost of manufacturing in the united states. >> we will be a net exporter of energy. >> yes, and it is a tremendous-- when we came into office in 2008 and 9, the predictions were we would have to be a big importer, twice as much, every predictions has been turned on our head this allows us a stronger manufacturing base and much stronger position in the world. if you put together that list of enduring strength, and you ask yourself would you want to trade places with anybody else in the world, the answer is no. >> rose: okay. i would just close with this bus i forgot to bring it up at the time. john kerry is involved in three big things. number one is iraq-- i mean iran, number two is sir ya, number three is israeli-p

i don't think it moves and he is waiting time on a priority that is not mercks. i honestly don't know why he's doing. i have spoken with former secretaries in the u.s. they don't know why he's doing it. i think that if i were advising kerry on what to do, you want to pick a couple countries that desperately need u.s. engage am, i would go south korea-japan. those are both allies, both countries that trust the u.s. the fact that their relationship right now is index orably broken. >> rose: top westerned back reb nell syria is forced to flee. >> yeah. >> rose: ef row day there is another story about what's happening to sort of the moderate rebels and the growth of the islamists. and almost taking over the opposition to assad. and then you see ryne crocker say maybe we should reengage with a. >> -- >> assad himself, counterterrorism and all the rest. >> rose: is that a doable idea. >> we are i guess engaging. look, first of all, some of the rebels are-- some of the moderates are turning to extremists because you know you kill over 100,000 people in a war, and you ha

and merck announcing any business focused on providing a obesity related health services.rmaceutical giant has lost a jim our weight management services to help provided diet, coaching and monitoring. that is the latest from the fox business network, giving you the power to prosper. ♪ [ female announcer ] there one thing dave's always wanted to do when he retires -- keep working, but for himself. so as his financial advisor, i took a look at everything he has. the 401(k). insurance pies. even money he'snvested elsewhere. we're building a retirement plan to help him launch a second career. dave's flight school. go dave. when people talk, great things can happen. so start a conversation with an advisor who's fully invested in you. wells fargo advisors. together we'll go far. ♪ dagen: another surprise for obamacare. connell: announcing an 11th hour rule changes that could impact health care for millions of americans. rich edson joins us from the white house to tell us the whole story. >> reporter: five to 6 million who have lost their health insurance plan. you don't have to

by the way, we're keeping an eye on the vixx, today back up again, and cater till bar, ge and merck arew. there's plenty of names hitting highs. back to you. cheryl: we'll see you in 14 minutes. time now for our monday panel, first up, critics launching first attacks on the sol kerr rule as five regulatory agencies gear up for a vote on the controversial financial regulation that aims to rein in risk taking on wall street. will the volcker rule actually do more harm than good? let's take it to our panel, charles payne, liz macdonald along with matt welsh, cohost of the fox business show that that debut t tonight at 9 p.m. eastern time. everybody is here. all right, matt, first to you. good to have bad, what do you say? >> bad. look, if you want to get rid of the problems that led to the great crash of 2008, get rid of the government guarantees that allowed people to make those risky bets knowing they would get bailed out either by fannie or freddie or by the government in terms of not allowing companies to fail. if you want companies to fail, let them fail -- dennis: cheryl, i think the

conservative country, but if you walk around in the 1970's you would see girls in skirts, very few women in merck is. people dressed in western-style clothing taking that -- is in taurus around to the sites. a radically, radically different place. one of the thing i tried to explore why change so dramatically. >> host: and that is so important. one of the most popular things we have ever run now website is a terrific fellow as a call once upon a time in afghanistan. and people just cannot get enough of the pictures of women in pencil skirts and sort of snazzy madman arad signature. absolutely. you know, sort of groovy records, hang out kind of clubs and stuff. you know, there was a sense of afghanistan on a development trajectory and actually, in the time before it all started to go down hell the u.s. was competing for influence in afghanistan, so you had both of them building these big projects, building the south. you know, the tunnel that connected afghanistan's north with the capital. i mean, these are incredible. there were moving society's board in significant ways. has been a very poor, la

you've also got merck in there, actually, ahead of mcdonald's, but these are -- they're just traditionalcks. i took a lot right before i came up, and believe it or not, the dogs of the dow did actually keep up with the s&p this year in performance -- at least very close to it, which i'm very surprised about, considering how strong the bull market's been. >> and you think ge could be in there. i mean, they're expected to raise their dividend as they've been doing lately. that could make the list at some point, too, right? >> they -- i mean they're going to raise their dividend. it will be any day. for all i know they did it in between the time they were miking me up for the show. they won't talk about that at ge. that's probably going to make it -- if they raise their dividends to what i think they will, which is just about 8% then they'll probably be in there. >> you know what's interesting about that is that a lot of these winners that jon is pointing out are actually up double digits this year. that goes from what i'm hearing from market strategists that i spoke to. many see winning se

merck? give me a break.s company is delivering. 7% to 13%, goes up to 8% to 14% and cyber monday is not included in these figures? >> they did point out the quarter was very tough to forecast, late holiday, contracts recently renewed that made this a tough number to estimate. >> can't they go after companies that are losers? >> nobody's really going after them. it's not like they have an activist in the ranks. there are some -- it's been -- we've talked about this. >> you ever hear a xanax? it's a franchise that could be unique to these head fund managers that are jittery about something like fedex. go take a xanax. >> i believe the stock prices reflect well, but you can always do more. >> you'd rather see up than down. >> yes, but we're a change company. the numbers for amazon -- by the way, you get free shipping today for a lot of guys. >> yes. >> there's the urgency is not as important given the fact that amazon has a warehouse next to your house. you don't need to do the expensive because amazon has put

holdings in that etf are some of the big consumer pharmaceutical giants johnson & johnson, pfizer, merckll start to slow and we'll see some new gainers coming forward in the pack? >> no, it was an excellent year for health care. and if you looked across the landscape, pharmaceutical companies lagged a bit. biotech was exceptionally strong, drug distributors, drugstores, it was a whole group of health care stocks that really helped lead this market in 2013. the question for '14 is less, really, what happens to the major pharma companies who are still coming out of this period of challenge and really now focused on pipeline. but what happens to the stocks that had 50%, 60% gains in 2013. that's the biggest call that investors are struggling with going into next year with this revaluation of so many parts of the health care sector, where should they be rotating their money in this coming years? >> they're all across the map. some of them are -- you have, for instance, a heart assistance device, you have a hospital, you have a couple other device companies. where are you finding value? >> i'

an allergist for merck. >> the two big groups that i see that would really benefit from this therapya doctor's office for a shot into their busy schedules and those who are needle adverse. >> reporter: but there is a tradeoff. the pills cover only specific graph pollen, while shots can offer broader protection to more allergens and be personalized for each individual. but some doctors caution while the pills may be more convenient, no one should sacrifice a doctor's supervisors. for "today," dr. nancy sneiderman, nbc news, new york. >>> take a look at this amazing basketball shot that was going viral even though it wasn't supposed to be a shot. he was trying to keep the ball from going out of bound, there you see there, he flipped it behind his back and swoosh 3 points the hard way. well done. it is 8:05 right now. it's time for the weather and al. . >> and we've got a brand-new teen ager, 13 years old today. what's your name? >> mary. >> mary, where are you guys from? >> memphis. >> it's a little cold for you in memphis. you know where it's nice and warm? our friends in north dakota

merck's family all back together after phil robertson.y winners today. >> so are the the ducks. and president small screen to the big screen hollywood set to cash in on jesus christ on the new year as has liberal hollywood turned or know how to make money? "fox & friends" hour two starts right now. >> live from new york, where we let the crew produce the show and pass the savings along to you, it's "fox & friends." >> that was the first mistake right there. we will take you back to 2002. look, it's mike and juliet on the couch again. >> you have guys met before? >> wow. >> i'm not juliet and philip. >> hi, welcome to "fox & friends" weekend. nice to see both of you. >> thanks for having us in. mike in from new philadelphia and juliet in from new york this morning. >> the phrases of 2013. >> picture. >> juliet on camera 4 or whatever camera is your camera. >> there we go. >> photo bomb. >> how many anchors does it take to figure out a photo bomb. >> janice photo bombing us. >> best photo bombs of 2013 coming up. some of them include pretty